Cardiovascular Check-up — Basic
The Basic Cardiovascular Check-up is an assessment of the main factors associated with cardiovascular risk and includes laboratory tests, a resting ECG, and a medical consultation.
The package allows assessment of lipid and glucose metabolism, additional markers associated with cardiovascular risk, and kidney function. The electrocardiogram complements the assessment by evaluating the electrical activity of the heart.
The results are interpreted together with clinical data and individual risk factors, such as age, blood pressure, smoking, and personal and family medical history.
Components
Total cholesterol, HDL, LDL, triglycerides
Assess the lipid profile and help identify dyslipidemia and the main lipid-related factors associated with atherosclerosis and cardiovascular risk.
Lipoprotein(a) – Lp(a)
A cardiovascular risk factor that is largely genetically determined. Elevated levels are associated with a higher risk of atherosclerotic cardiovascular disease. Lp(a) measurement is useful for complementing cardiovascular risk assessment and is generally recommended at least once during adulthood.
Glucose
Assesses blood glucose at the time of sample collection and contributes to the identification of disorders of glucose metabolism.
Glycated hemoglobin – HbA1c
Reflects the average blood glucose level over approximately the previous 2–3 months and contributes to the identification and monitoring of glucose metabolism disorders.
High-sensitivity C-reactive protein – hs-CRP
A sensitive marker of low-grade systemic inflammation. Persistently elevated levels, in the absence of acute infection or inflammation, may represent an additional factor in cardiovascular risk assessment.
eGFR (CKD-EPI) + Serum creatinine
Assess kidney function. Impaired kidney function is closely associated with cardiovascular risk and may influence prevention, monitoring, and treatment strategies.
12-lead resting ECG
Assesses the heart rhythm and electrical conduction and may reveal arrhythmias, conduction abnormalities, signs of ventricular hypertrophy, or other electrocardiographic changes.
Medical consultation included in the package – General Practitioner
The physician integrates the laboratory and ECG results with the patient's medical history and individual risk factors and determines whether preventive measures, monitoring, or additional investigations are required.
Role of the assessment
The package provides an initial cardiovascular assessment by combining the main metabolic and biological risk factors with an evaluation of the heart's electrical activity.
The investigations may contribute to:
- identifying dyslipidemia;
- identifying disorders of glucose metabolism;
- assessing Lp(a) as an additional cardiovascular risk factor;
- assessing an inflammatory marker associated with cardiovascular risk;
- evaluating kidney function;
- identifying electrocardiographic abnormalities;
- complementing the overall assessment of cardiovascular risk;
- determining the need for preventive measures, monitoring, or additional investigations.
Indications
- preventive cardiovascular assessment;
- presence of multiple cardiovascular risk factors: arterial hypertension, dyslipidemia, diabetes/prediabetes, obesity, smoking, or a sedentary lifestyle;
- family history of myocardial infarction, stroke, or premature cardiovascular disease;
- need for reassessment of cardiovascular risk as recommended by a physician;
- monitoring of individuals with known cardiovascular risk factors.
Medical sources:
https://www.escardio.org/guidelines/practice-tools/cvd-prevention-toolbox/score-risk-charts
https://www.escardio.org/guidelines/clinical-practice-guidelines/all-esc-practice-guidelines/dyslipidaemias
https://www.eshonline.org/esh-content/uploads/2025/12/2024-ESH-MASTERplan-Blood-Pressure_publication_2025-1-1.pd
http://https://academic.oup.com/eurheartj/article/45/36/3538/7738955
https://academic.oup.com/eurheartj/article/42/34/3227/6358713
http://https://academic.oup.com/eurheartj/article/45/38/3912/7741010